4SC-302

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name4SC-302
Drug Alias Namedihydroorotate dehydrogenase (DHODH) inhibitor (4SC)4SC-302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsFlavivirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies4sc Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4sc Ag
Active IndicationsN/A
Inactive IndicationsFlavivirus Infections

Other Information

ATC CodeN/A
Related LinksN/A